For Patients & General Readers
Immune Thrombocytopenia (ITP) is a bleeding disorder where your body's immune system mistakenly attacks and destroys its own platelets, which are essential for blood clotting. This can lead to easy bruising and bleeding. While it can affect anyone, it's more common in children and women, and it's important to manage to prevent serious bleeding complications.
Clinical Overview
Immune Thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia (platelet count < 100 x 10^9/L) in the absence of other identifiable causes. It results from autoantibodies and/or cellular immunity directed against platelet glycoproteins, leading to increased platelet destruction and impaired production.
Clinical Presentation
- Isolated thrombocytopenia (<100 x 10^9/L) on peripheral blood smear.
- Absence of other causes of thrombocytopenia (e.g., infections, medications, other autoimmune diseases, malignancy).
- Bone marrow aspirate typically shows normal or increased megakaryocytes.
- Variable bleeding symptoms, ranging from asymptomatic to severe hemorrhage.
- Diagnosis is often made after exclusion of other causes of thrombocytopenia.
Signs & Symptoms
Symptoms (Patient-Reported)
- Easy bruising (ecchymoses)
- Petechiae (small, pinpoint red or purple spots on the skin)
- Nosebleeds (epistaxis)
- Bleeding gums
- Prolonged bleeding from cuts
- Heavy menstrual bleeding (menorrhagia)
- Blood in urine (hematuria) or stool (melena)
Signs (Clinician-Observed)
- Petechiae and purpura
- Ecchymoses
- Splenomegaly (may be present in some cases)
- Evidence of active bleeding (e.g., hematemesis, hematochezia)
Differential Diagnoses
| Condition | Distinguishing Feature |
|---|
| Drug-induced thrombocytopenia | Temporal relationship to medication initiation and resolution upon drug withdrawal. |
| Thrombotic Thrombocytopenic Purpura (TTP) | Presence of microangiopathic hemolytic anemia, neurological abnormalities, and renal impairment. |
| Hemolytic Uremic Syndrome (HUS) | Prominent renal involvement and diarrhea (especially in Shiga toxin-producing E. coli-associated HUS). |
| Systemic Lupus Erythematosus (SLE) with thrombocytopenia | Presence of other SLE manifestations (e.g., rash, arthritis, serositis, positive autoantibodies). |
| Myelodysplastic Syndromes (MDS) | Morphological abnormalities in other cell lines (e.g., anemia, neutropenia) and often dysplastic changes in bone marrow. |
| Viral infections with transient thrombocytopenia | Association with acute viral illness and usually self-limiting thrombocytopenia. |
Red Flags — Seek Immediate Care
- Platelet count < 10 x 10^9/L, especially with bleeding symptoms.
- Evidence of active or severe bleeding (e.g., intracranial hemorrhage, gastrointestinal bleeding).
- Sudden onset of severe thrombocytopenia or rapid decline in platelet count.
- Neurological symptoms suggestive of intracranial hemorrhage.
Key Investigations
- Complete blood count (CBC) with differential to confirm thrombocytopenia and assess other cell lines.
- Peripheral blood smear to assess platelet morphology and rule out fragmented red blood cells or other abnormalities.
- Coagulation studies (PT, aPTT) to rule out disseminated intravascular coagulation (DIC).
- Liver function tests and renal function tests to assess for organ involvement.
- Antibody testing for platelet-associated antibodies (PAA) or anti-platelet factor 4 (PF4) antibodies (less sensitive and specific, often reserved for complex cases).
- Bone marrow aspirate and biopsy (indicated if diagnosis is uncertain, refractory to treatment, or in older patients to rule out MDS).
Management Overview
Management of ITP is guided by symptom severity and platelet count, aiming to prevent bleeding. First-line treatment typically involves corticosteroids (e.g., prednisone) to suppress the immune system, or intravenous immunoglobulin (IVIg) for rapid platelet count elevation. Refractory or severe cases may require splenectomy, thrombopoietin receptor agonists (TPO-RAs), or immunosuppressive agents.
Disclaimer: This article is for educational purposes only and does not constitute medical advice.
Always consult a qualified healthcare professional for diagnosis and treatment.
TruelyserMD does not replace clinical judgement.